
1309: Vaxsaline
AIDS Vaccine Comparison, Global Economic Health Arguments
The hosts question why a COVID-19 vaccine was developed in less than a year while an AIDS vaccine has remained elusive for decades despite billions in spending. They critique the argument that "nobody is safe until everybody is safe," suggesting it is a rhetorical tool for vaccine nationalism. The discussion highlights the contradiction of using Big Pharma as a solution for a crisis they are accused of exploiting.












